ITIH4 and viral infectious disease: Other nonneutralizing C1-C2 gp120-specific antibodies tested (CH54, CH57, CH90, and V1V2 CH58 IgG) also did not block virus infection in the ex vivo explant model, nor were they protective in the high-dose mucosal SHIV challenge.